EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reducing Neuroinflammation via Inhibition of Fibrinogen Deposition and Microglial Activation as an Underlying Mechanism of Paning I Decoction in Ameliorating Parkinson's Disease Symptoms

Yan-Jun Chen, Jing-Wen Chen, Ming-Rong Xie, Rui-Zhen Wang, Yu-Ling Wan, Jie Zeng, Bing-Wu Zhong, Sheng-Qiang Zhou, Fang Liu iD

Immunity, Inflammation and Disease · 2026-02 · 14 (2)

DOI: 10.1002/iid3.70310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 05.02.2026. Verfasst von Yan-Jun Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hunan University of Chinese Medicine, Changsha, China. Hauptthemen laut MEDLINE: Microglia, Fibrinogen, Neuroinflammatory Diseases, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: 2nd Lushan Xinglin Talent Project of Hunan Academy of Chinese Medicine, The 2nd Zhaoyang Talent Project of Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Hunan Furong Program-Young Health Professionals Talent.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease (PD) is a major neurodegenerative disorder. Some patients show limited response to standard therapies, driving the need for new complementary treatments. Paning I decoction (PNID), a traditional herbal formula, has shown the potential to alleviate PD symptoms, but its exact mechanisms remain unclear.

Methods

We tested PNID in a mouse model of PD induced by a 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP). Mice received different PNID doses to evaluate symptom alleviation. We used behavioral tests and laboratory analyses to study brain changes, including neuron damage assessment, dopamine and tyrosine hydroxylase (TH) measurements, blood–brain barrier (BBB) integrity and microglia evaluation, and inflammatory marker analysis.

Results

PNID treatment alleviated PD symptoms in a dose‐dependent manner. High‐dose PNID performed similarly to Madopar. Neuron protection: increased dopamine and TH expression. BBB repair: less leakage and fibrinogen accumulation. Regulation of polarization: shifted microglia from M1 to M2 states. Inflammation control: lowered pro‐inflammatory factors (IL‐6, IL‐1β, and TNF‐α) while increasing anti‐inflammatory factors (IFN‐β, IL‐10, and IL‐4).

Conclusions

PNID may serve as a promising complementary therapy for PD. Benefits may come from the repair of the BBB, reduction of fibrinogen deposition, and decline in neuroinflammation by modulating microglial polarization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaFibrinogenNeuroinflammatory DiseasesDrugs, Chinese HerbalParkinson DiseaseAnimalsMiceMaleBlood-Brain BarrierDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

Paning I decoctionParkinson's diseasefibrinogenmicroglianeuroinflammation

Substanzen

FibrinogenDrugs, Chinese Herbal

Autor:innen und Institutionen

  • Hunan University of Chinese Medicine, Changsha, China.
  • National TCM Master Liu Zuyi Inheritance Studio, Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine, Changsha, China.
  • Nanjing University of Chinese Medicine, Nanjing, China.
  • The Second Xiangya Hospital, Central South University, Changsha, China.

ORCID-Profile: Fang Liu

Förderung

  • 2nd Lushan Xinglin Talent Project of Hunan Academy of Chinese Medicine
  • The 2nd Zhaoyang Talent Project of Hunan Provincial Hospital of Integrated Traditional Chinese and Western Medicine
  • Hunan Furong Program-Young Health Professionals Talent
  • Hunan Provincial Talent Office), and the Postgraduate Research Innovation Project of Hunan Province

Zitieren

APA

Chen, Y. J., Chen, J. W., Xie, M. R., Wang, R. Z., Wan, Y. L., Zeng, J., Zhong, B. W., Zhou, S. Q., & Liu, F. (2026). Reducing Neuroinflammation via Inhibition of Fibrinogen Deposition and Microglial Activation as an Underlying Mechanism of Paning I Decoction in Ameliorating Parkinson's Disease Symptoms. Immunity, Inflammation and Disease, 14(2). https://doi.org/10.1002/iid3.70310

Vancouver

Chen YJ, Chen JW, Xie MR, Wang RZ, Wan YL, Zeng J, et al. Reducing Neuroinflammation via Inhibition of Fibrinogen Deposition and Microglial Activation as an Underlying Mechanism of Paning I Decoction in Ameliorating Parkinson's Disease Symptoms. Immunity, Inflammation and Disease. 2026;14(2). doi:10.1002/iid3.70310

BibTeX
@article{Chen2026,
  author = {Chen, Yan-Jun and Chen, Jing-Wen and Xie, Ming-Rong and Wang, Rui-Zhen and Wan, Yu-Ling and Zeng, Jie and Zhong, Bing-Wu and Zhou, Sheng-Qiang and Liu, Fang},
  title = {Reducing Neuroinflammation via Inhibition of Fibrinogen Deposition and Microglial Activation as an Underlying Mechanism of Paning I Decoction in Ameliorating Parkinson's Disease Symptoms},
  journal = {Immunity, Inflammation and Disease},
  year = {2026},
  volume = {14},
  number = {2},
  doi = {10.1002/iid3.70310}
}
Kostenlos starten →